Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pain × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 39 Stomach Neoplasms 26 Pancreatic Neoplasms 14 Rectal Neoplasms 13 Neoplasms 8 Neoplasm Metastasis 8 Squamous Cell Carcinoma of Head and Neck 7 Esophageal Neoplasms 7 Adenocarcinoma Of Esophagus 7 Adenocarcinoma 7 Head and Neck Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Carcinoma, Hepatocellular 6 Esophageal Squamous Cell Carcinoma 5 Colonic Neoplasms 5 Biliary Tract Neoplasms 5 Advanced Solid Tumors 5 Ovarian Neoplasms 4 Nasopharyngeal Carcinoma 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Peritoneal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Locally Advanced Rectal Cancer 2 Endometrial Neoplasms 2 Colorectal Cancer Metastatic 2

Interventions

Surveys and Questionnaires 2 Saline Solution 2 Acetaminophen 2 siltuximab 1 pegfilgrastim 1 oxycodone-acetaminophen 1 erenumab 1 Triamcinolone Acetonide 1 Triamcinolone 1 Transcranial Direct Current Stimulation 1 Touch 1 Telemedicine 1 Standard of Care 1 Oxycodone 1 Morphine 1 Methods 1 Mastectomy 1 Laughter Therapy 1 Ketorolac Tromethamine 1 Ketorolac 1 Fluorouracil 1 Exercise 1 Duloxetine Hydrochloride 1 Dronabinol 1 Curettage 1 Chewing Gum 1 Caregivers 1 Anesthesia, Local 1 Acupuncture, Ear 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡